When a woman is pregnant or thinking about pregnancy, conversations about vaccines can feel especially loaded. A new survey is trying to get a clearer picture of how doctors are having those talks about COVID-19 shots. It's asking clinicians across the U.S. about their current recommendations and practices for women of reproductive age. The survey doesn't report any results yet—it's just collecting information. This means we don't know what doctors are actually saying, what challenges they face, or if there are common misunderstandings they're trying to clear up. The findings, when they come, could help identify where better support or clearer guidance is needed for both patients and their healthcare providers. For now, it's simply an effort to listen to the people on the front lines of these important conversations.
Survey explores clinician COVID-19 vaccination practices for women of reproductive ageHow do doctors talk to women about COVID vaccines? A new survey asks
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Note: This is a descriptive survey report with no specific results provided.
A survey report describes a study of clinicians in the United States who offered or administered COVID-19 vaccines to women of reproductive age, which included pregnant patients. The study type was a survey, and key details such as sample size, specific interventions or exposures, comparators, primary and secondary outcomes, and follow-up duration were not reported.
No main results, including quantitative findings or specific clinician practices, were provided in the available data. Safety and tolerability information, including adverse events, serious adverse events, and discontinuations, were also not reported. The report did not detail any specific study limitations or information regarding funding or conflicts of interest.
The practice relevance of the findings was not reported. Given the descriptive nature of this report and the absence of specific results or methodological details, it serves only to indicate that such a survey was conducted. It does not provide evidence to guide clinical practice.
What this means for you:
A survey is asking doctors how they discuss COVID vaccines with women. More on COVID
E3 ubiquitin ligases modulate SARS-CoV-2 replication and immune evasion through targeted protein degradation mechanisms
SARS-CoV-2 uses host enzymes to hide from the immune system
This mini-review explores the role of E3 ubiquitin ligases in the context of SARS-CoV-2 infection. The authors synthesize how these enzymes …
New research shows how the virus hijacks specific proteins in our cells to replicate and dodge our body's natural defenses.
Patients with post-COVID syndrome face significant thromboembolic risk requiring proactive monitoring and tailored anticoagulant treatments
Anticoagulant Drugs May Help Manage Thromboembolic Risks After COVID-19
This meta-analysis examines the prevalence of thromboembolic events in individuals with post-COVID syndrome. The analysis identifies a signi…
People with post-COVID syndrome may face a higher risk of blood clots, highlighting the need for proactive monitoring and tailored treatment…
Casirivimab plus imdevimab reduced risk of hospitalization or death in patients with and without asthma
Trial shows antibody treatment helps COVID-19 patients with asthma
This randomized controlled trial evaluated casirivimab plus imdevimab (CAS + IMD) in outpatients with acute COVID-19. The study found that C…
A new trial shows a dual antibody treatment reduces hospitalization and death risk for COVID-19 patients, including those with asthma or ato…
Erratum issued for COVID-19 hospitalization data among health care personnel
What happened to health care workers hospitalized with COVID-19? A correction notice.
An erratum notice was published regarding data on COVID-19-associated hospitalizations among health care personnel from the COVID-NET survei…
A correction notice clarifies that a previous report on health care workers hospitalized with COVID-19 did not contain new data or findings.
View Original Abstract ↓
This report describes results from a survey of clinicians who offered or administered COVID-19 vaccines to women of reproductive age, including pregnant patients.
Adjuvant radiotherapy improves recurrence-free survival for intermediate-risk cervical cancer patients after surgery
Adjuvant radiotherapy improves recurrence-free survival for early-stage cervical cancer patients
Related in OB/GYN & Women's Health
Single-cell RNA sequencing reveals trophoblast and immune mechanisms in preeclampsia pathogenesis
New Sequencing Methods Reveal Hidden Mechanisms of Preeclampsia
This systematic review of single-cell RNA sequencing studies identifies impaired trophoblast differentiation, invasion, and senescence, alon…
Advanced single-cell sequencing reveals how specific cells and molecules contribute to the development of preeclampsia during pregnancy.
Gut microbiota dysbiosis shows strong observational link to endometriosis in reproductive-aged women
Gut bacteria linked to endometriosis, review finds
This narrative review examines the association between gut microbiota dysbiosis and endometriosis in reproductive-aged women. The authors re…
A review of studies finds a strong link between gut bacteria imbalances and endometriosis, but can't prove cause and effect.
Datopotamab deruxtecan showed no overall survival benefit versus investigator's choice chemotherapy in metastatic HR-positive breast cancer.
Datopotamab deruxtecan extends life for advanced breast cancer patients
This Phase III randomized controlled trial evaluated datopotamab deruxtecan versus investigator's choice chemotherapy in patients with inope…
New drug datopotamab deruxtecan helps advanced breast cancer patients live longer and stay disease-free
Low-intensity cervical screening shows similar CIN2+ risk to high-intensity screening in HPV-vaccinated women
Study finds similar cervical cancer risk with less frequent screening for HPV-vaccinated women
An RCT in Finland followed 5626 women vaccinated against HPV16/18 as adolescents, comparing low-intensity to high-intensity cytology-based s…
HPV-vaccinated women aged 12 to 15 face the same cervical cancer risk whether screened every three years or every five years, according to n…
From Other Specialties
Prenatal 6:2 Cl-PFESA exposure is associated with lower birth weight in infants across specific sub-analyses
Chemical in everyday products linked to lower birth weight
This meta-analysis of 12 studies examined the association between prenatal 6:2 Cl-PFESA exposure and infant birth weight. While no overall s…
A common chemical may reduce newborn weight by up to 20 grams. New analysis of 12 studies raises concerns for fetal health.
Reducing social media use to 1 hour daily significantly reduces loneliness in youth
Limiting Social Media Use Reduces Loneliness in Youth with Anxiety
This randomized controlled trial of 219 youth with anxiety or depression found that limiting social media use to 1 hour per day for three we…
Youth with anxiety and depression felt less lonely after voluntarily limiting their social media use to one hour per day for three weeks.
GLP-1R exposure shows no causal link to most mental disorders except eating disorders
GLP-1 Receptor Agonists Show Mixed Links to Mental Health
This meta-analysis investigated the causal associations between GLP-1 receptor agonists and various mental health outcomes including anxiety…
New research explores how GLP-1 receptor agonists relate to conditions like anxiety and depression, finding no clear genetic link to most di…
Sacubitril/Valsartan preserves left ventricular systolic function and attenuates GLS deterioration during chemotherapy
Sacubitril and Valsartan May Protect Heart Function During Chemotherapy
This meta-analysis of randomized controlled trials evaluates sacubitril/valsartan for patients undergoing chemotherapy to manage chemotherap…
A new review suggests the medication sacubitril/valsartan may help preserve heart muscle function for patients undergoing chemotherapy.